Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-20 Sale |
2024-11-22 4:47 pm |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
19,824 | $94.31 | $1,869,658 | 5,430 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-17 4:55 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
90,000 | $1.0533 | $94,797 | 914,359 (Direct) |
View |
| 2023-11-10 Purchase |
2023-11-13 5:31 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
10,000 | $1.01 | $10,100 | 824,359 (Direct) |
View |
| 2023-06-29 Purchase |
2023-06-29 4:13 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
10,000 | $2.16 | $21,600 | 814,359 (Direct) |
View |
| 2023-06-23 Purchase |
2023-06-26 4:04 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
20,000 | $2.3371 | $46,742 | 804,359 (Direct) |
View |
| 2023-06-22 Purchase |
2023-06-22 4:01 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
40,000 | $2.31 | $92,400 | 784,359 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-20 Exercise |
2024-11-22 4:47 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
7,500 | $69.79 | 5,430 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 4:47 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
1,312 | $76.24 | 5,430 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 4:47 pm |
N/A 2028-06-21 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
8,812 | $0 | 5,430 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | COATS LONNEL Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 5:37 pm |
N/A 2034-06-12 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
6,812 | $0 | 17,824 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-02-29 4:26 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
61,371 | $2.62 | 1,430,198 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 4:26 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
245,080 | $0 | 1,430,198 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 4:12 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
1,540,840 | $0 | 1,540,840 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 7:04 pm |
N/A 2032-06-21 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
7,900 | $0 | 16,312 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:00 pm |
N/A 2033-06-14 |
Verve Therapeutics Inc. | VERV | COATS LONNEL Director |
26,642 | $0 | 26,642 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-01 4:46 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
50,971 | $2.17 | 960,419 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-01 4:46 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
209,327 | $0 | 960,419 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 4:55 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
1,444,590 | $0 | 1,444,590 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-09 5:05 pm |
N/A 2032-08-07 |
Verve Therapeutics Inc. | VERV | COATS LONNEL Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-30 9:57 pm |
N/A 2032-06-21 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
7,900 | $0 | 13,712 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:11 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
48,053 | $2.85 | 737,300 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:11 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
197,343 | $0 | 737,300 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:05 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
1,096,370 | $0 | 1,096,370 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:19 pm |
N/A 2031-06-02 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
6,750 | $0 | 10,312 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
55,038 | $7.19 | 685,353 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
192,885 | $0 | 685,353 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:10 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2020-06-24 Option Award |
2020-06-26 4:11 pm |
N/A 2030-06-24 |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
6,750 | $0 | 8,062 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-23 4:19 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | COATS LONNEL Director |
1,312 | $0 | 1,312 (Direct) |
View |